2016-2026年心血管領域的合作與授權合約

Cardiovascular Collaboration and Licensing Deals 2016-2026

出版日期: 2026年10月01日 | 出版商:

Current Partnering | 英文 350+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

我們將利用基於 664 個案例研究的合作關係和許可協議信息，了解心血管領域合作關係的趨勢。

《2016-2026 年心血管合作與許可交易》提供了有關 664 項與心血管資產、技術和開發計劃相關的合作交易的全面資訊。

我們在心血管領域的合作涵蓋了多種治療適應症、技術和開發階段，從早期研究合作到授權和商業化協議。

本報告將這些活動匯總到一個資源中，使用戶能夠了解哪些公司正在合作，哪些心血管機會正在吸引關注，交易結構是什麼，披露了哪些財務條款，以及交易如何因適應症、技術和開發階段而異。

這份報告不只是簡單地列出了交易清單；它結合了全面的市場交易分析和財務基準、主要交易商的信息、個別交易記錄以及公開的合約文件。

本報告為參與心血管合作的業務發展、許可、研究和評估、公司策略、研發策略、競爭情報和法律團隊提供了實用的資訊來源和基準。

了解心血管領域的合作趨勢

本報告分析了2016年至2026年心血管領域的交易情況，內容包括：

心血管領域合作的年度趨勢
按交易類型分類的交易活動
產業部門
合作關係發展階段
技術類型
心血管疾病治療的適應症
心血管領域最活躍的交易商
根據已披露的交易金額，主要交易
心血管領域合作活動的趨勢
這使用戶能夠確定他們的活動集中在哪些方面，並了解哪些公司、技術、開發階段和治療領域正在吸引合作興趣。
心血管領域交易財務資訊的基準分析
財務條款可能因心血管資產的性質、開發階段、技術、授予的權利和交易結構而有很大差異。

本報告對已揭露的財務狀況進行了詳細分析，包括以下項目：

交易總額
預付款
里程碑付款
特許權使用費率
透過分析這些基準背後的具體交易，用戶可以更全面地了解所揭露條件的經濟背景。
這為內部基準測試、機會評估和交易準備提供了一個現實的基準。
財務基準只有在結合類似交易的結構和情況進行解讀時才最有用，而不僅僅是作為平均值。本報告提供了建立這種背景所需的基礎交易資訊。
確定心血管領域的關鍵交易撮合者和潛在的未來夥伴。
該報告列出了在心血管領域合作活動最活躍的公司，並提供了交易歷史記錄，以便用戶可以調查這些公司過去的活動。

這有助於用戶識別以下內容：

積極尋求心血管領域商機的公司
潛在的許可和合作研究合作夥伴
我們曾多次與一些組織就特定心血管疾病適應症合作。
積極參與開發過程的公司
對特定技術或方法表現出興趣的交易商
競爭對手採取類似的外部創新策略
對於尋求心血管資產和技術合作夥伴的公司而言，過去的交易歷史可以提供寶貴的見解，了解哪些組織對類似的機會表現出了興趣。
我們將比較心血管疾病各適應症領域的合作活動。
心血管疾病涵蓋多個不同的治療領域和發展策略。
本報告按心血管疾病的治療適應症分析交易，使用戶能夠探索與特定項目和策略興趣領域最相關的交易，以及廣泛的市場層級基準。
透過結合基於技術和發展階段的分析，使用者可以更集中地了解類似的交易活動。
我將了解心血管疾病領域的合約結構。
本報告涵蓋合作關係、授權、開發、研究和其他合作交易。

根據交易詳情和資訊披露，用戶可以調查以下方面：

授予和保留的權利
研發職責
授權權
獨家版權
區域權利
智慧財產
發展和監管義務
負責生產和供應
商業化權利
金錢補償
里程碑和版稅
管治
合約期限和終止條款
在考慮心血管領域合作的適當框架時，這些例子將作為有用的參考資料。
從實際合約文件中學習
本報告提供部分心血管相關交易的基礎合約文件（如有）。

這些協議提供了僅憑新聞標題無法獲得的詳細信息，並幫助用戶了解每家公司如何記錄以下內容：

權利範圍
發展義務
智慧財產
獨家版權
財務狀況
里程碑觸發條件
特許權使用費規定
商業化權利
合約終止及其他談判事項
對於準備和談判心血管領域合作研究和許可協議的團隊來說，實際的合約措辭可以提供有關類似交易在實踐中如何構建的寶貴見解。
綜合心血管交易目錄
本報告包含一份全面的目錄，收錄了心血管領域的 664 項合作與許可協議，提供了識別相關領先交易的詳細資訊來源。

可以使用以下條件搜尋交易記錄：

公司
技術類型
治療指徵
合約揭露狀態
每筆交易都與其底層交易記錄相關聯，從而可以存取詳細的交易資訊和相關的合約文件（如有）。
誰該使用這份報告？
業務拓展與授權團隊
找出可比較的心血管相關交易、潛在的未來夥伴以及相關的交易結構。
研究與評估團隊
我們尋找那些在心血管領域積極探索特定適應症、技術和發展階段商機的公司。
尋求合作夥伴的生技公司
找出對類似心血管相關資產和技術表現出明顯興趣的組織。
企業策略與研發策略團隊
我們將了解我們的競爭對手和潛在合作夥伴如何透過外部創新來建立其心血管產品線。
競爭情報與市場情報團隊
按公司、適應症、開發階段和技術追蹤合作趨勢，以了解不斷變化的策略重點。
法律及交易團隊
我們將仔細審查公開的合約和以往的合約結構，以幫助您準備和談判交易。
我們將整個循環系統市場的訊息轉化為針對特定公司的洞察。
對於符合資格的客戶，Current Partnering 不僅會提供報告，還會為高階主管提供客製化的合作關係簡報。
本簡報將運用心血管交易的基本訊息，闡述您具體的資產、技術、指標或合作目標。
如有需要，我們可以提供相關的類似交易、潛在合作夥伴關係、競爭對手活動、發展階段分析、交易結構、財務基準、忠誠度分析、合約見解以及其他專門為您情況選擇的資訊。
請索取樣本或聯絡 Current Partnering 討論報告內容以及我們是否可以為貴公司提供客製化分析。

The report brings this activity together in one resource, enabling users to understand who is partnering, which cardiovascular opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.

Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, individual transaction records and access to publicly available contract documents where available.

It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in cardiovascular partnering.

Understand the cardiovascular partnering landscape

The report analyzes cardiovascular dealmaking from 2016 to 2026, including:

Trends in cardiovascular partnering by year
Deal activity by deal type
Industry sector
Stage of development at the time of partnering
Technology type
Cardiovascular therapeutic indication
Most active cardiovascular dealmakers
Leading deals by disclosed value
How cardiovascular partnering activity is evolving
This enables users to identify where activity is concentrated and understand which companies, technologies, development stages and therapeutic areas are attracting partnering interest.
Benchmark cardiovascular deal financials
Financial terms can vary considerably according to the nature of the cardiovascular asset, development stage, technology, rights granted and transaction structure.

The report provides dedicated analysis of disclosed financial terms, including:

Headline deal values
Upfront payments
Milestone payments
Royalty rates
Users can then investigate the individual transactions behind these benchmarks to understand the wider context surrounding the disclosed economics.
This provides real-world reference points for internal benchmarking, opportunity assessment and deal preparation.
Financial benchmarks are most useful when interpreted alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
Identify leading cardiovascular dealmakers and prospective partners
The report identifies the most active companies in cardiovascular partnering and provides transaction histories that enable users to investigate their previous activity.

This can help users identify:

Companies actively seeking cardiovascular opportunities
Prospective licensing and collaboration partners
Organizations repeatedly partnering in particular cardiovascular indications
Companies active at relevant stages of development
Dealmakers demonstrating interest in specific technologies or approaches
Competitors pursuing similar external innovation strategies
For companies seeking to partner a cardiovascular asset or technology, previous transaction activity can provide useful evidence of which organizations have demonstrated an appetite for comparable opportunities.
Compare partnering activity across cardiovascular indications
Cardiovascular disease encompasses multiple distinct therapeutic areas and development strategies.
The report analyzes deals by cardiovascular therapeutic indication, allowing users to move beyond broad market-level benchmarks and investigate the transactions most relevant to a particular program or area of strategic interest.
Combined with analysis by technology and development stage, this enables users to develop a more focused view of comparable deal activity.
Understand how cardiovascular agreements are structured
The report includes collaboration, licensing, development, research and other partnering transactions.

Depending on the transaction and available disclosure, users can investigate areas including:

Rights granted and retained
Research and development responsibilities
Licensing rights
Exclusivity
Geographic rights
Intellectual property
Development and regulatory obligations
Manufacturing and supply responsibilities
Commercialization rights
Financial consideration
Milestones and royalties
Governance
Term and termination provisions
These real-world examples provide useful reference points when considering the appropriate structure for a cardiovascular partnership.
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected cardiovascular transactions.

These agreements can provide significantly more detail than headline announcements alone, helping users examine how companies have documented areas such as:

Scope of rights
Development obligations
Intellectual property
Exclusivity
Financial terms
Milestone triggers
Royalty provisions
Commercialization rights
Termination and other negotiated provisions
For teams preparing or negotiating a cardiovascular collaboration or licensing agreement, real contract language provides valuable insight into how comparable transactions have been structured in practice.
Comprehensive cardiovascular deal directory
The report includes a comprehensive directory of 664 cardiovascular collaboration and licensing deals, providing a detailed resource for identifying relevant precedent transactions.

Deals can be reviewed by:

Company
Technology type
Therapeutic indication
Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
Who should use this report?
Business Development and Licensing teams
Identify comparable cardiovascular deals, prospective partners and relevant transaction structures.
Search and Evaluation teams
Understand which companies are actively seeking cardiovascular opportunities across particular indications, technologies and stages of development.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable cardiovascular assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and prospective partners are building cardiovascular pipelines through external innovation.
Competitive and Market Intelligence teams
Track partnering activity by company, indication, development stage and technology to understand evolving strategic priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Turn market-wide cardiovascular intelligence into company-specific insight
For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
The briefing applies the underlying cardiovascular deal intelligence to the customer's own asset, technology, indication or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.